Latest Research

Microfluidics for CRISPR-based multiplexed detection of nucleic acids

Abstract

“Fast, inexpensive, and multiplexed detection of multiple nucleic acids is of great importance to human health, yet it still represents a significant challenge. Herein, we propose a nucleic acid testing platform, named MiCaR, which couples a microfluidic device with CRISPR-Cas12a and multiplex recombinase polymerase amplification. With only one fluorescence probe, MiCaR can simultaneously test up to 30 nucleic acid targets through microfluidic space coding. The detection limit achieves 0.26 attomole, and the multiplexed assay takes only 40 min. We demonstrate the utility of MiCaR by efficiently detecting the nine HPV subtypes targeted by the 9-valent HPV vaccine, showing a sensitivity of 97.8% and specificity of 98.1% in the testing of 100 patient samples at risk for HPV infection. Additionally, we also show the generalizability of our approach by successfully testing eight of the most clinically relevant respiratory viruses. We anticipate this effective, undecorated and versatile platform to be widely used in multiplexed nucleic acid detection.

a Brief overview of the steps involved in the subtyping process. The collected cervical cell specimen is first thermolyzed. Then, RPA is performed to amplify the nine HPV subtypes. The amplicons are subsequently tested via the CRISPR-Cas12a system on the microfluidic device, followed by fluorescence imaging to obtain the readout. b On-chip testing principles. A 30-plexed starburst-shaped chip (SS-Chip) with one central inlet connected to 30 outlets is used. The outlets are preloaded with various Cas12a/crRNAs that recognize the relevant target HPV subtype. After the on-chip assay, the fluorescent readout at specific outlets (i.e., space coding) indicates the presence of relevant HPV subtypes in the sample.” Reproduced under a Creative Commons Attribution 4.0 International License from Xu, Z., Chen, D., Li, T. et al. Microfluidic space coding for multiplexed nucleic acid detection via CRISPR-Cas12a and recombinase polymerase amplification. Nat Commun 13, 6480.

 

Figures and the abstract are reproduced from Xu, Z., Chen, D., Li, T. et al. Microfluidic space coding for multiplexed nucleic acid detection via CRISPR-Cas12a and recombinase polymerase amplification. Nat Commun 13, 6480 (2022). https://doi.org/10.1038/s41467-022-34086-y under a Creative Commons Attribution 4.0 International License.

Read the original article: Microfluidic space coding for multiplexed nucleic acid detection via CRISPR-Cas12a and recombinase polymerase amplification

Pouriya Bayat

Published by
Pouriya Bayat

Recent Posts

Multiphasic Droplet Microfluidics for Controlled Bacteria and Mammalian Cell Co-Culture

Studying interactions between bacteria and mammalian cells is important for understanding the microbiome, infection, inflammation,…

August 3, 2026

Handheld Microfluidic Platform for Rapid Thrombin and SARS-CoV-2 Spike Protein Detection

Rapid detection of thrombin and SARS-CoV-2 spike protein is useful for very different clinical needs,…

July 20, 2026

Artificial Red Blood Cells for Microfluidic Hemorheology

Blood is difficult to recreate in the lab because its flow behavior is not controlled…

July 7, 2026

Profiling Live Neuronal Cell Membrane Integrity with Microfluidic Electrorotation

Cell membrane damage is deeply connected to many diseases, including neurodegenerative disorders such as Parkinson’s…

June 26, 2026

What is a Microfluidics Chip?

Imagine a laboratory that fits in the palm of your hand. Though it might sound…

June 25, 2026

Detecting Antibiotic Resistance with Droplet Microfluidics and Image Texture Analysis

Antibiotic resistance is not always easy to detect. In some bacterial infections, most cells may…

June 15, 2026